Monkeypox: What We Know (and What We Don’t)

The longer and farther the virus spreads, the more likely it could become endemic in new areas, says UCLA epidemiologist Anne Rimoin.

Written byAndy Carstens
| 7 min read
Aerial view of crowd connected by lines
Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Update (November 28): The World Health Organization announced today that, to avoid the potential for racist and stigmatizing language, it will begin using the term “mpox” for the disease and will phase out the use of “monkeypox.”

Update (July 25): The World Health Organization held a press conference on July 23 during which the organization’s director-general, Tedros Adhanom Ghebreyesus, declared that the monkeypox outbreak now constitutes a public health emergency of international concern. Despite the WHO’s advisory committee not reaching consensus on the matter when they met on July 21, Ghebreyesus says several of the criteria for declaring a global health emergency have been satisfied. Because there have now been 16,000 cases reported across 75 countries and territories, he says that the WHO’s assessment is that the risk of monkeypox is high in Europe but moderate elsewhere, adding that there is a “clear risk of further international spread.” Because the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot of Andrew Carstens

    Andy Carstens is a freelance science journalist who is a current contributor and past intern at The Scientist. He has a bachelor’s degree in chemical engineering from the Georgia Institute of Technology and a master’s in science writing from Johns Hopkins University. Andy’s work has previously appeared in AudubonSlateThem, and Aidsmap. View his full portfolio at www.andycarstens.com.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies